Riskpilot← Back to searchSign inGet full accessCMCHoldings ApS
APSActiveCVR 37842648Nordre Fasanvej 215Activities of holding companies · NACE 6421Est. 2016— employees
Revenue 2024
DKK -10K
+5% vs 2023
EBITDA margin
100.0%
-5% vs 2023
Equity ratio
86.6%
Financial strength
Net profit 2024
DKK 421K
-25% vs 2023
| Revenue | DKK -10K | +5% |
| EBITDA | DKK -10K | -5% |
| Net profit | DKK 421K | -25% |
| Total assets | DKK 3,2M | +20% |
| Equity | DKK 2,8M | +12% |
| Employees | — | — |
Legal name
CMCHoldings ApS
CVR number
37842648
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
1. juli 2016
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene, eller af hele direktionen i forening.
Company purpose
Selskabets formål er at foretage investeringer i aktiviteter, som leverer rådgivning og serviceydelser relaterede til udvikling og fremstilling af biofarmaceutiske produkter, proces- og analytisk udvikling, produktions-opskalering og cGMP-fremstilling af biologisk aktive farmaceutiske ingredienser til prækliniske og kliniske forsøg, og at udføre aktiviteter, der er forbundet hermed, herunder enhver form for investeringsaktivitet.
Address
Nordre Fasanvej 215
Phone
+4529624262
Email
jens@cmcassist.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -12 | -8 | -8 | -8 | -64 | -9 | -10 | -10 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -12 | -8 | -8 | -8 | -64 | -9 | -10 | -10 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -12 | -8 | -8 | -8 | -64 | -9 | -10 | -10 |
| Net financials | 448 | 555 | 1.337 | 214 | 673 | -697 | 606 | 492 |
| Profit before tax | 436 | 547 | 1.329 | 207 | 610 | -706 | 596 | 481 |
| Tax | 0 | -12 | -1 | 10 | 4 | -39 | 32 | 60 |
| Net profit | 435 | 559 | 1.331 | 197 | 606 | -667 | 565 | 421 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 881 | 1.239 | 2.895 | 2.360 | 2.990 | 2.191 | 2.650 | 3.184 |
| Equity | 485 | 945 | 2.175 | 2.272 | 2.778 | 2.011 | 2.458 | 2.757 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 396 | 294 | 719 | 88 | 212 | 180 | 193 | 427 |
| Total debt | 396 | 294 | 719 | 88 | 212 | 180 | 193 | 427 |
EBITDA margin
-1024400.0%
This company
15.8%
Market median
-6483644% vs market
20172024
Equity ratio
86.6%
This company
38.2%
Market median
+127% vs market
20172024
Return on equity
15.3%
This company
18.4%
Market median
+17% vs market
20172024
Net profit margin
42148000.0%
This company
8.1%
Market median
+520345579% vs market
20172024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20172024
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20172024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.0% | 50.0% | 2021 | |
| Individual | 50.0% | 50.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CMCHoldings ApS 
CMCGreenhouse ApSBoard members of CMCHoldings ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|